Azurity Pharm. v. Bionpharma Inc.

Full title: AZURITY PHARMACEUTICALS, INC., Plaintiff-Appellant v. BIONPHARMA INC.…

Court: United States Court of Appeals, Federal Circuit

Date published: Mar 9, 2022

No. 2021-1926 (Fed. Cir. Mar. 9, 2022)

Opinion

2021-1926 2021-1927

03-09-2022

AZURITY PHARMACEUTICALS, INC., Plaintiff-Appellant v. BIONPHARMA INC., Defendant-Appellee

Richard Torczon, Wilson, Sonsini, Goodrich & Rosati, PC, Washington, DC, argued for plaintiff-appellant. Also represented by Ty William Callahan, Granville Clayton Kaufman, Los Angeles, CA; Wendy L. Devine, Nicholas Sylvester Halkowski, Kristina M. Hanson, San Francisco, CA; Natalie J. Morgan, San Diego, CA. Andrew M. Alul, Taft, Stettinius & Hollister, LLP, Chicago, IL, argued for defendant-appellee. Also represented by Roshan Shrestha.

Per Curiam

This disposition is nonprecedential.

Appeals from the United States District Court for the District of Delaware in Nos. 1:18-cv-01962-LPS, 1:19-cv-01067-LPS, Judge Leonard P. Stark.

Richard Torczon, Wilson, Sonsini, Goodrich & Rosati, PC, Washington, DC, argued for plaintiff-appellant. Also represented by Ty William Callahan, Granville Clayton Kaufman, Los Angeles, CA; Wendy L. Devine, Nicholas Sylvester Halkowski, Kristina M. Hanson, San Francisco, CA; Natalie J. Morgan, San Diego, CA.

Andrew M. Alul, Taft, Stettinius & Hollister, LLP, Chicago, IL, argued for defendant-appellee. Also represented by Roshan Shrestha.

JUDGMENT

This Cause having been heard and considered, it is

Ordered and Adjudged:

Per Curiam

(Newman, Clevenger, and Stoll, Circuit Judges.)

AFFIRMED. See Fed. Cir. R. 36.